European Monoclonal Antibodies Market Trends, Size, Competitive Analysis and Forecast 2020-2026

European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for monoclonal antibodies has been reported in the region, owing to the rising demand for novel monoclonal antibody therapies with higher safety and efficacy in the region. For instance, in June 2020, the European Commission has approved Sarclisa (isatuximab), a monoclonal antibody along with pomalidomide and dexamethasone (pom-dex) to treat adult patients suffering from relapsed and refractory multiple myeloma. These are intended for multiple myeloma patients who have received a minimum of two prior therapies such as a proteasome inhibitor and lenalidomide and have shown the progression of the condition on the last therapy. 

To Request a Sample of our Report on European Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/european-monoclonal-antibodies-market

As a monoclonal antibody, Sarclisa attaches to a particular epitope on the CD38 receptor of multiple myeloma cells. This approval offers a crucial additional therapeutic alternative and will offer a new treatment for myeloma patients who require new potential treatments as their disease has become refractory to their earlier treatment disease or has returned. Sarclisa along with pom-dex shown median progression-free survival of approximately one year. The launch of novel monoclonal antibodies therapies will lead to drive safety and effectiveness of the therapy, which in turn, will further accelerate the market growth.

Scope of the European Monoclonal Antibodies Market

Market Coverage

·        Market number available for 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Source and Application

·        Countries Covered- UK, Germany, France, Spain, Italy, and Rest of Europe

·        Competitive Landscape- AstraZeneca plc, Pfizer Inc., Sitryx Therapeutics Ltd., Orchard Therapeutics plc, and Mylan N.V.

Recent Strategic Initiatives in the European Monoclonal Antibodies Market

·        In April 2020, Pfizer Inc. declared the European Commission approval of RUXIENCE (rituximab). It is a monoclonal antibody and biosimilar to MabThera (rituximab), which aims to treat granulomatosis with polyangiitis, chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, rheumatoid arthritis, microscopic polyangiitis, and pemphigus vulgaris. The biosimilars' approval including RUXIENCE is an essential development to treat certain cancers and autoimmune conditions. It offers effectiveness to improve access to treatment access while minimizing healthcare costs. 

·        In January 2020,  Roche declared that the European Commission has permitted conditional marketing authorization for Polivy (polatuzumab vedotin), along with bendamustine plus MabThera (rituximab) (BR), to treat adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are not candidates for a haematopoietic stem cell transplant.

(Get 15% Discount on Buying this Report)

A full Report of European Monoclonal Antibodies Market is Available at: https://www.omrglobal.com/industry-reports/european-monoclonal-antibodies-market

European Monoclonal Antibodies Market-Segmentation

By Source

·        Murine

·        Chimeric

·        Human

·        Humanized

By Application

·        Cancer

·        Infectious Diseases

·        Auto-Immune Diseases

·        Inflammatory Diseases

·        Others

European Monoclonal Antibodies Market– Segment by Country 

·        Germany

·        UK

·        France

·        Spain

·        Italy

Rest of Europe

Company Profiles

·        AstraZeneca plc

·        Bayer AG

·        Bristol-Myers Squibb Co.

·        F. Hoffmann-La Roche AG

·        Genmab A/S

·        GlaxoSmithKline plc

·        Innate Pharma S.A.

·        Mylan N.V.

·        Novartis AG

·        Pfizer Inc.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-monoclonal-antibodies-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more